Biomolecular Markers of Bone Metastasis
ConditionBone Metastasis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
About this trial
The goal of this clinical trial is to characterize the biomolecular profile of bone metastases to define the predisposing profiles of bone metastasis, in patients with breast or lung or renal carcinomas or of the gastroenteric or prostate tract with bone metastasis.
The main question it aims to answer is:
Is it possible to predict the progression of bone metastasis by identifying biomarkers as risk factors for bone metastasis?
Eligibility criteria
Qualifiers
Age >= 18 years
Patients with breast or lung or renal or gastroenteric tract or prostate with bone metastases
Patients who knowingly express willingness to participate in the study after signing the written informed consent
Disqualifiers
None
Trial design
Treatments tested in this trial
- Biomolecular profile of bone metastases
Treatment groups
160 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov